Steven D. Munger, PhD, assistant professor of Anatomy and Neurobiology at the University of Maryland School of Medicine has received the 2003 Presidential Early Career Award for Scientists and Engineers.
Scientists have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease. The discovery could one day lead to the prevention, and possibly to the treatment, of autoimmune diseases such as Type 1 diabetes.
Angela H. Brodie, Ph.D., professor of pharmacology and experimental therapeutics at the University of Maryland School of Medicine, has won the prestigious Charles F. Kettering Prize for her pioneering work in developing aromatase inhibitors.
Experts from the professional schools at the University of Maryland, Baltimore and the University of Maryland Medical Center can discuss many different aspects of Hurricane Katrina and its aftermath.
To address the growing mental health needs of today's youth, the University of Maryland School of Medicine's Center for School Mental Health Analysis and Action will bring together mental health experts, educators and policy makers at a two-day conference to discuss ways to bring mental health services to youth in the school setting.
New research published in JAMA Psychiatry reveals that topiramate, a drug approved by the U.S. Food and Drug Administration (FDA) to treat epilepsy and migraine headaches, also could be the first reliable medication to help treat cocaine dependence.
Scientists at the Institute for Genome Sciences at the University of Maryland School of Medicine and physicians at Sinai Hospital, Baltimore, MD, have found that restoring the normal, helpful bacteria of the gut and intestines may treat patients suffering from recurrent Clostridium difficile infections. Transplanting fecal matter of healthy donors into patients with recurrent C. difficile infection (RCDI) appears to restore normal bacterial composition and resolve infection. The study findings appear in the November 26th issue of PLOS ONE.
NIH Director Francis Collins was the keynote speaker at a conference that kicked off University of Maryland School of Medicine’s Accelerating Innovation and Discovery in Medicine (ACCEL-Med) program in which the medical school asked a panel of world-famous scientists to act as advisors and consultants on where the School’s research efforts should be.
Investigators at the Institute for Genome Sciences at the University of Maryland School of Medicine have developed a new technique that can track the activity of a disease-causing microbe and the host cell response to that pathogen simultaneously. Using the new method to examine Chlamydia trachomatis infection, the study team observed how the response of the infected cell contributes to one of the hallmark outcomes of chlamydial disease --tissue scarring.
Robust partnerships between rural community health education centers and academic health care institutions can make substantial strides toward addressing race-, income- and geographically-based health disparities in underserved communities by empowering both the community and leading University institutions.
Adding bevacizumab (Avastin) to standard chemotherapy and radiation treatment does not improve survival for patients newly diagnosed with the often deadly brain cancer glioblastoma, researchers report in the Feb. 20 issue of the New England Journal of Medicine.
Researchers at the Institute for Genome Sciences at the University of Maryland School of Medicine have been awarded a research program contract from the U.S. Food and Drug Administration (FDA) to sequence, assemble, and annotate a population of bacterial pathogens using two high-throughput sequencing (HTS) technologies in support of the expansion of a vetted public reference database.
Cervical cancer rates in the United States are higher than previously believed, particularly among 65- to 69-year-old women and African-American women, according to a study led by a researcher at the University of Maryland School of Medicine published in the journal Cancer. Current U.S. cervical cancer screening guidelines do not recommend routine Pap smears for women over 65 if their prior test results have been normal.
Researchers at the University of Maryland School of Medicine have identified a mutation in a fat-storage gene that appears to increase the risk for type 2 diabetes and other metabolic disorders, according to a study published online today in the New England Journal of Medicine.
The National Institutes of Health (NIH) has awarded a four-year, $3.7 million grant to researchers at the University of Maryland School of Medicine to develop a personalized medicine program to help doctors diagnose and treat monogenic diabetes – a form of diabetes caused by a mutation in a single gene.
A team of leading experts in radiation oncology from the University of Maryland School of Medicine (UM SOM) have published an opinion piece in the Aug. 1 issue of the medical publication The Cancer Letter, stating that several types of cancer patients requiring radiation therapy would benefit from specialized proton beam therapy as a treatment method over the more commonly used radiation methods.
On Friday, September 12 between 1 pm EDT to 2 pm EDT the Global Virus Network, with support from UST Global as a technology partner, will host a WebEx conference including three GVN world-renowned Ebola experts and journalists from across the globe.
More than 90 percent of potential pediatric fractures are splinted improperly in emergency rooms and urgent care centers, which can lead to swelling and skin injuries, according to a study by researchers at the University of Maryland School of Medicine. The findings are being presented at the American Academy of Pediatrics (AAP) National Conference & Exhibition in San Diego.
The Baltimore study is the second Ebola vaccine trial being led by the University of Maryland School of Medicine CVD, the first currently taking place in Mali, West Africa. The Mali trial is being performed by CVD-Mali in partnership with the Ministry of Health of Mali.
New research from scientists at the University of Maryland School of Medicine (UM SOM) has found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration (AMD), a degenerative eye disease that can cause severe vision loss and blindness. This is the first time these mineral deposits have been implicated in the disease, which affects more than 10 million Americans. The article appeared in the latest issue of the Proceedings of the National Academy of Sciences.
After eight years of analysis, scientists from around the world have completed an unprecedented project to delineate a wide spectrum of human genetic variation. This enormous catalog of data, known as the 1000 Genomes Project, will yield insights for decades. Scientists from the University of Maryland School of Medicine played a key role in the consortium, and co-authored two papers published this week about the effort in the current issue of the journal Nature.
The Association of American Medical Colleges announced that University of Maryland School of Medicine Dean E. Albert Reece will receive the 2015 David E. Rogers Award, which honors a medical school faculty member who has made major contributions to improving the health and health care of the American people.
In an event that showed the growing breadth and depth of research at the University of Maryland School of Medicine, more than 500 attendees participated in the Third Annual Festival of Science on December 11.
The Center for Vaccine Development at the University of Maryland School of Medicine will participate in a partnership with industry to develop a vaccine to prevent a group of deadly bacterial infections that occur commonly among hospital patients.
The University of Maryland School of Medicine has been selected as a key contractor by the Biomedical Advanced Research and Development Authority for its Radiation Nuclear Animal Model Development program.
Research performed by scientists at the University of Maryland School of Medicine has led to FDA approval for the use of a drug to treat the deleterious effects of radiation exposure following a nuclear incident. The drug, Neulasta, is one of a few that have been approved for the treatment of acute radiation injury.
The White House has awarded Robert E. Fischell, ScD, a member of the University of Maryland School of Medicine Board of Visitors, the National Medal of Technology and Innovation, the highest honor for technological achievement bestowed by the president of the United States.
As it spreads throughout South and Central America and beyond, Zika presents a unique challenge to health officials and to the public. University of Maryland School of Medicine infectious disease specialists can offer insight into the virus, its potential hazards, and the possibility that it may spread to the U.S.
William F. Regine, Chairman of the Department of Radiation Oncology at the University of Maryland School of Medicine, along with Dean E. Albert Reece, today announced the establishment of the Maryland Proton Alliance, a new organizational framework for proton therapy at the school that may serve as a national model for patient-centered cancer care. The Alliance will be led by Zeljko Vujaskovic, Professor in the Department of Radiation Oncology and head of the department’s Division of Translational Radiation Sciences.
The Maryland House of Delegates and House Speaker Michael E. Busch, has announced that University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA and University of Maryland Medical System President and CEO Robert Chrencik, MBA, are recipients of the “Speaker’s Medallion,” the highest honor given to the public by the leader of the Maryland House of Delegates.
The University of Maryland School of Medicine announced today that the Maryland Proton Treatment Center has treated its first cancer patients with proton therapy at a new $200 million facility in the University of Maryland BioPark in West Baltimore.
New research has provided more evidence that an innovative treatment strategy may help prevent brain swelling and death in stroke patients. J. Marc Simard, professor of neurosurgery at the University of Maryland School of Medicine, along with colleagues at Yale University and Massachusetts General Hospital, found that Cirara, an investigational drug, powerfully reduced brain swelling and death in patients who had suffered a type of large stroke called malignant infarction, which normally carries a high mortality rate.
The University of Maryland School of Medicine has appointed Peter B. Crino as Chairman of the department of neurology. Dr. Crino has spent his career studying and developing new models for treating some of the most difficult and complex disorders of the brain. He is an expert in defining developmental disorders associated with intractable epilepsy.
The the University of Maryland School of Medicine Program in Health Disparities and Population Health now has a new home in the Department of Epidemiology and Public Health.
Zeljko Vujaskovic, MD, PhD, an internationally recognized physician scientist and Professor of Radiation Oncology at the University of Maryland School of Medicine (UM SOM), will receive the 2016 J. Eugene Robinson Award at the annual Society for Thermal Medicine Meeting in New Orleans, held April 11 to 15. Dr. Vujaskovic, who is also Director of the Division of Translational Radiation Sciences in the UM SOM Department of Radiation Oncology, and Director of the Maryland Proton Alliance at UM SOM, will receive the award in recognition of his contributions to hyperthermic oncology, the use of heat to treat cancer. At the event, Dr. Vujaskovic will also present a lecture on the reemerging role of thermal therapy in cancer treatment.
It is one of the most famous paintings in American history: Christina’s World, by Andrew Wyeth. The subject in the painting suffered from a mysterious disorder that took away her ability to walk. Her disease has never been diagnosed. Now, a leading neurologist has pinpointed a diagnosis.
Each year, influenza causes between 250,000 and half a million deaths around the world. Now a new study has shown that immunizing mothers against flu can decrease by 70 percent the risk of their infants getting flu during the first four months after birth. This is the largest study so far to show that maternal vaccination against flu is feasible and effective in resource-poor environments.
In a milestone years in the making, a vaccine to prevent cholera was approved today by the U.S. Food and Drug Administration (FDA). The vaccine, Vaxchora, is the only approved vaccine in the U.S. for protection against cholera. Its licensure allows for use in people traveling to regions in which cholera is common, including travelers, humanitarian aid workers, and the military.
The Center for Vaccine Development (CVD) has been awarded a large grant for research that will help determine why so many children under five are dying in the world’s poorest countries. The grant will fund use of an innovative alternative to traditional autopsy known as minimally invasive tissue sampling.
Charles B. Simone, II has been named the new Medical Director of the Maryland Proton Treatment Center. Dr. Simone will continue to define and implement processes ensuring that MPTC is integrated into the radiation oncology program and the University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center/System, and the University of Maryland School of Medicine.
Most people don’t think of fungal infections as deadly – they are generally viewed as annoyances – athlete’s foot, for instance. But for many weakened patients in the hospital, fungal infections can be life threatening. Now, a new study has provided insights into one of these microbes, the Mucorales fungi, which can cause fatal infections.
For more than a century, neuroscientists have known that nerve cells talk to one another across the small gaps between them, a process known as synaptic transmission. But the details of how this crucial aspect of brain function occurs have remained elusive. Now, new research has for the first time elucidated details about the architecture that Allows Brain Cells to Communicate. The paper was published today in the journal Nature.
The Center for Vaccine Development at the University of Maryland School of Medicine’s Institute for Global Health has been chosen as one of three study sites in a human safety trial of a new Zika vaccine. The early-stage study will evaluate the experimental vaccine’s safety and ability to generate an immune system response in participants.
Using a new, lightning-fast camera paired with an electron microscope, University of Maryland School of Medicine scientists have captured images of one of the smallest human proteins to be “seen” with a microscope.
An international group of researchers has for the first time identified a set of 30 inherited recessive genes that play a role in intellectual disability, a neurodevelopmental disorder that affects as many as 213 million people around the world.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. To reduce this risk, doctors have prescribed low molecular weight heparin. But some researchers argue that aspirin may be just as effective. A comprehensive new study will try to resolve this question.
Researchers have confirmed for the first time that two of the top genomic databases, which are in wide use today by clinical geneticists, reflect a measurable bias toward genetic data based on European ancestry over that of African ancestry. The results of their study were published in the latest issue of Nature Communications.
The University of Maryland in College Park and the University of Maryland, Baltimore today unveiled ambitious plans for the Center for Sports Medicine, Health and Human Performance.